Publications by: Patrick N.A. Harris

Also publishes as (Patrick Harris, P. Harris)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 6.

Harris, Patrick N.A., Peleg, Anton Y., Iredell, Jon, Ingram, Paul R., Miyakis, Spiros, Stewardson, Andrew J., Rogers, Benjamin A., McBryde, Emma S., Roberts, Jason A., Lipman, Jeff, Athan, Eugene, Paul, Sanjoy K., Baker, Peter, Harris-Brown, Tiffany, and Paterson, David L. (2015) Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 16 (24). pp. 1-8.

Harris, P., Eales, K.M., Squires, R., Govan, B., and Norton, R. (2013) Acute Q fever in northern Queensland: variation in incidence related to rainfall and geographical location. Epidemiology and Infection, 141 (5). pp. 1034-1038.

Harris, P., Siew, D-A., Proud, M., Buettner, Petra, and Norton, R. (2011) Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clinical Microbiology and Infection, 17 (8). pp. 1216-1222.

Harris, Patrick N.A., Williams, Natasha L., Morris, Jodie L., Ketheesan, Natkunam, and Norton, Robert E. (2011) Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay. Clinical and Vaccine Immunology, 18 (8). pp. 1288-1291.

Harris, Patrick, Engler, Cathy, and Norton, Robert (2011) Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin. International Journal of Antimicrobial Agents, 37 (6). pp. 547-549.

Harris, Patrick N.A., Ketheesan, Natkunam, Owens, Leigh, and Norton, Robert E. (2009) Clinical features that affect Indirect-Hemagglutination-Assay responses to Burkholderia pseudomallei. Clinical and Vaccine Immunology, 16 (6). pp. 924-930.

This list was generated on Fri Mar 24 12:12:33 2017 AEST.